Doumas, Michael

Exercise Capacity and Mortality in Older Men: A 20-Year Follow-Up Study

Kokkinos, P., Myers, J., Faselis, C., Panagiotakos, D. B., Doumas, M., Pittaras, A., Manolis, A., Kokkinos;, J. P., Karasik, P., Greenberg, M., et al. (2010) · Circulation

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 328

Cardiorespiratory Fitness and Mortality Risk Across the Spectra of Age, Race, and Sex

Kokkinos, P., Faselis, C., Samuel, I. B. H., Pittaras, A., Doumas, M., Murphy, R., Heimall, M. S., Sui, X., Zhang, J., & Myers, J. (2022) · Journal of the American College of Cardiology

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 259

Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study

Kokkinos, P. F., Faselis, C., Myers, J., Panagiotakos, D., & Doumas, M. (2013) · The Lancet

Lipoproteins and Cardiovascular HealthPhysical Activity and Health

Cited by 217

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes

Papademetriou, V., Lovato, L., Doumas, M., Nylen, E., Mottl, A., Cohen, R. M., Applegate, W. B., Puntakee, Z., Yale, J. F., & Cushman, W. C. (2015) · Kidney International

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 210

C5a and TNF-α Up-Regulate the Expression of Tissue Factor in Intra-Alveolar Neutrophils of Patients with the Acute Respiratory Distress Syndrome

Kambas, K., Markiewski, M. M., Pneumatikos, I. A., Rafail, S. S., Theodorou, V., Konstantonis, D., Kourtzelis, I., Doumas, M. N., Magotti, P., DeAngelis, R. A., et al. (2008) · The Journal of Immunology

Blood Coagulation and Thrombosis MechanismsRespiratory Support and Mechanisms

Cited by 127

Exercise capacity and mortality in hypertensive men with and without additional risk factors.

Kokkinos, P., Manolis, A., Pittaras, A., Doumas, M., Giannelou, A., Panagiotakos, D. B., Faselis, C., Narayan, P., Singh, S., & Myers, J. (2009) · Hypertension

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 120

Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of cardiovascular outcome trials.

Patoulias, D. I., Boulmpou, A., Teperikidis, E., Katsimardou, A., Siskos, F., Doumas, M., Papadopoulos, C. E., & Vassilikos, V. (2021) · World Journal of Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: A Milestone Achieved

Sarafidis, P., Papadopoulos, C. E., Kamperidis, V., Giannakoulas, G., & Doumas, M. (2021) · Hypertension

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 39

Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?

Stavropoulos, K., Imprialos, K. P., Katsiki, N., Petidis, K., Kamparoudis, A., Petras, P., Georgopoulou, V., Finitsis, S., Papadopoulos, C., Athyros, V. G., et al. (2018) · The Journal of Clinical Hypertension

Hormonal Regulation and HypertensionAdrenal and Paraganglionic Tumors

Cited by 23

Exercise blood pressure, cardiorespiratory fitness and mortality risk

Kokkinos, P., Faselis, C., Sidossis, L., Zhang, J., Samuel, I. B. H., Ahmed, A., Karasik, P., Pittaras, A., Doumas, M., Grassos, C., et al. (2021) · Progress in Cardiovascular Diseases

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 16

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation

Athyros, V. G., Katsiki, N., Dimakopoulou, A., Patoulias, D., Alataki, S., & Doumas, M. (2019) · Current Pharmaceutical Design

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 12